Diabetes complications

Oleanolic Acid‐Enriched Olive Oil Attenuates Kidney Function Decline in Patients With Type 2 Diabetes: Results From the OLTRAD Randomised Controlled Trial

Diabetes Obes MetabPublished Secondary analysis of the OLTRAD randomised controlled trial

Authors' conclusion

In this exploratory, hypothesis-generating secondary analysis, long-term consumption of OA-enriched olive oil was associated with attenuated kidney function decline in patients with T2DM, an effect limited to those with baseline mildly impaired eGFR. These changes were associated with modulation of AGE-related pathways and reduced oxidative stress.

Study context

Population
Patients with T2DM
Participants
97 patients
Comparison
Oleanolic acid (OA)-enriched olive oil vs control olive oil
Primary endpoint
Kidney function decline: eGFR and uACR
Follow-up
12 months
Methodological detailsprespecified, exploratory, Trial powered for glycemic control rather than renal outcomes
  • Prespecified
  • Exploratory
  • Trial powered for glycemic control rather than renal outcomes

Primary result

As reported in the abstract

eGFR decline
  • OA-enriched olive oil attenuated estimated glomerular filtration rate (eGFR) decline vs control, restricted to participants with mildly impaired baseline eGFR (60-90 mL/min/1.73 m²)
  • No significant interaction among participants with normal baseline eGFR
  • OA-enriched oil prevented the rise in urinary albumin-to-creatinine ratio (uACR) observed with control oil
  • OA-enriched olive oil vs Control olive oil: time × group interaction p = 0.010
  • Exploratory, hypothesis-generating

Further findings

AGE metabolism

OA reduced AR concentration and increased GloxI activity, lowering circulating MG; CML unchanged

Oxidative stress markers

OA-enriched oil reduced ROS and MDA; MDA increased with control oil

Original publication

Oleanolic Acid‐Enriched Olive Oil Attenuates Kidney Function Decline in Patients With Type 2 Diabetes: Results From the OLTRAD Randomised Controlled Trial. Diabetes Obes Metab. Published 17 August 2026. doi:10.1111/dom.71206

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.